https://www.thebodypro.com/category/meeting-costs-hiv-care/tag/conference-coverage

The Latest

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid Img

Staying on PrEP is Significantly Different for PrEP Users With Commercial Insurance Versus Medicaid

Young adults, blacks, cisgender women, and people in rural areas, as well as people on Medicaid, were less likely to persist on PrEP.

Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say Img

Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say

The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.

HIV Prevalence Among Non-Medicaid Expansion States

Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade

The lack of Medicaid expansion in the South is creating worse racial disparities in the U.S., according to researchers and medical providers discussing the HIV care cascade at CROI 2018.

$1 Million in Funding to Help HIV Organizations Impacted by Hurricanes Harvey and Irma Announced at USCA Img

$1 Million in Funding to Help HIV Organizations Impacted by Hurricanes Harvey and Irma Announced at USCA

Donated by Gilead Sciences, the $1 million fund to help HIV organizations impacted by Hurricanes Harvey and Irma was announced at the opening of the 21st annual U.S. Conference on AIDS in Washington, D.C.

ACA's Medicaid Expansion Significantly Increased Coverage and Clinical Outcomes for People With HIV Img

ACA's Medicaid Expansion Significantly Increased Coverage and Clinical Outcomes for People With HIV

Due to the impact of the Affordable Care Act (ACA), in just two years the proportion of people living with HIV in care covered by Medicaid increased from 36% to 42% and the proportion that were uninsured fell from 18% to 14%.

The Need to Advocate for Fair HIV Drug Prices Img

The Need to Advocate for Fair HIV Drug Prices

"Drug prices are too high and your access to your drugs is in danger. So, wake up and get ready!" says Lynda Dee of the Fair Pricing Coalition.

1,000-Fold Mark-Up for Drug Prices in High Income Countries Blocks Access to HIV, HCV and Cancer Drugs Img

1,000-Fold Mark-Up for Drug Prices in High Income Countries Blocks Access to HIV, HCV and Cancer Drugs

An opening lecture at the 2016 Glasgow HIV Congress challenged the current model of drug pricing in high-income countries by showing mark-ups that are sometimes more than 1,000 times higher than production costs making many medicines largely unafford...

New Antiretrovirals Could Mean Savings Up to $3 Billion by 2025 Img

New Antiretrovirals Could Mean Savings Up to $3 Billion by 2025

The introduction of three new antiretrovirals into treatment programmes in low- and middle-income countries -- tenofovir alafenamide fumarate (TAF), low-dose efavirenz (Sustiva, Stocrin) and dolutegravir (Tivicay, DTG) -- could represent over $3 bill...

Higher Rate of Viral Suppression Found in ACA Enrollees Than in Those Supported Only by Ryan White Img

Higher Rate of Viral Suppression Found in ACA Enrollees Than in Those Supported Only by Ryan White

Low-income HIV-positive people enrolled in Affordable Care Act (ACA) health plans in Virginia had better health outcomes than those receiving care through the state's direct AIDS Drug Assistance Program (ADAP), in which people are typically treated a...

International Activists Confront Gilead Over Hepatitis C Drug Pricing at AIDS 2014 Img

International Activists Confront Gilead Over Hepatitis C Drug Pricing at AIDS 2014

An international group of treatment activists interrupted a session at AIDS 2014 just as Gregg H. Alton, a top official at Gilead Sciences, was about to speak regarding the challenges of expanding global access to the new generation of hepatitis C dr...